Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development.
The new research team will be led by Dr. Douglas McCloskey, a scientist and entrepreneur jointly selected by the Sanofi and BioMed X Institute
Jun 30, 2023BioMed X has announced that it has begun a joint research project with Sanofi on artificial intelligence (AI) driven drug development.
BioMed X and Sanofi begin joint research on AI-driven drug development. This latest effort is yet another AI play from BioMed X, hoping to capitalise on a rapidly growing market. BioMed X has announced that it has begun a joint research project with Sanofi on artificial intelligence (AI)-driven drug development.
Heidelberg, June 29, 2023.
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE).
The team can benefit from the resources and expertise of a pre-existing industry cluster, joining eight other active research teams at the BioMed X institute in Heidelberg, Germany.
